This observation is particularly important because it demonstrates that these drugs can remain effective even in the absence of the MC4R pathway, which is traditionally thought to play a key role in regulating energy balance and appetite
The prescriber should still evaluate the diagnosis, available approved alternatives, evidence quality, contraindications, potential interactions, monitoring plan, and whether the proposed benefit justifies uncertainty
If you do not respond adequately to semaglutide after three to four months, switching to tirzepatide remains an option
Apply morning and evening to the face, neck, and dcollet
No, there isn't a universal KLOW dosage guide